Question

Herceptin, a drug developed by the biotechnology industry, is used to treat breast cancer. It is taken only after a patient undergoes a matching diagnostic test. In this way, the drug is only give to those patients who have a certain protein. What is the main benefit of such a technology?
A. Less time for development is needed since fewer people get the drug.
B. Costs to the consumers will be greatly reduced.
C. Only those who will benefit receive the drug.
D. Fewer testing requirements will allow the drug to be released sooner.

Answer 1

C i think....

Answer 2

okay thanks

Answer 3

welcome